GS

Gurjit Singh

Active Director Director DIN 10204357
DIN 10204357 First appointment Jun 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Gurjit Singh

Data last updated:

Gurjit Singh is a Director at Ghpsbio Pharma Technologies Private Limited (since 2023). Ghpsbio Pharma Technologies Private Limited reported revenue of ₹89.4 Lakh (FY 2024).

DIN 10204357
Primary Designation Director
First Appointment 12 Jun 2023
Oldest Company Age 3 yrs
Largest company Ghpsbio Pharma Technologies Private Limited · ₹89.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jun 20232023₹89.4 Lakh (FY 2024)Active

Board colleagues of Gurjit Singh

NameDINCompanyDesignation
Parwinder Kaur10204356Ghpsbio Pharma Technologies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ghpsbio Pharma Technologies Private Limited
Premium access

Shareholding and investment profile for Gurjit Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurjit Singh

Gurjit Singh currently holds 1 directorship: Ghpsbio Pharma Technologies Private Limited (Director, since 12 Jun 2023, revenue ₹89.4 Lakh (FY 2024)).

Gurjit Singh was first appointed on 12 Jun 2023 as Director at Ghpsbio Pharma Technologies Private Limited.

The current boards of Gurjit Singh's companies include Parwinder Kaur (Ghpsbio Pharma Technologies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available